Analyst Ratings For Cardinal Health Inc (NYSE:CAH)
Today, Royal Bank of Canada set its price target on Cardinal Health Inc (NYSE:CAH) to $60.00 per share.
There are 8 Hold Ratings, 3 Buy Ratings, 2 Sell Ratings, no Strong Buy Ratings on the stock.
The current consensus rating on Cardinal Health Inc (NYSE:CAH) is Hold with a consensus target price of $61.6667 per share, a potential 11.78% upside.
Some recent analyst ratings include
- 8/12/2018-Cardinal Health Inc (NYSE:CAH) had its Hold rating reiterated by Mizuho with a $53.00 price target
Recent Insider Trading Activity For Cardinal Health Inc (NYSE:CAH)
Cardinal Health Inc (NYSE:CAH) has insider ownership of 0.97% and institutional ownership of 87.86%.
- On 8/20/2018 Jon L Giacomin, CEO, sold 2,890 with an average share price of $51.95 per share and the total transaction amounting to $150,135.50.
- On 2/20/2018 Jon L Giacomin, CEO, sold 7,995 with an average share price of $68.78 per share and the total transaction amounting to $549,896.10.
- On 2/14/2018 Patricia Morrison, Insider, sold 28,532 with an average share price of $66.30 per share and the total transaction amounting to $1,891,671.60.
- On 1/22/2018 Michael C Kaufmann, CEO, sold 18,586 with an average share price of $73.90 per share and the total transaction amounting to $1,373,505.40.
- On 5/12/2017 Jon L Giacomin, CEO of Cardinal Health’s pharmaceutical segment, sold 23,270 with an average share price of $72.87 per share and the total transaction amounting to $1,695,684.90.
- On 2/10/2017 George S Barrett, Chairman, sold 217,994 with an average share price of $77.23 per share and the total transaction amounting to $16,835,676.62.
- On 11/10/2016 George S Barrett, Chairman, sold 217,995 with an average share price of $71.29 per share and the total transaction amounting to $15,540,863.55.
About Cardinal Health Inc (NYSE:CAH)
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. The company operates through two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. It also provides services to support the development, marketing, and distribution of specialty pharmaceutical products, as well as pharmacy management, and medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; and repackages generic pharmaceuticals and over-the-counter healthcare products. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products. It also distributes a range of national brand products; and medical products to patients' homes, as well as provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.
Recent Trading Activity for Cardinal Health Inc (NYSE:CAH)
Shares of Cardinal Health Inc closed the previous trading session at 55,17 up +1,23 2,28 % with 54.03 shares trading hands.
